Overview


According to FutureWise analysis the market for Synthetic Biology in 2023 is US$ 14.34 billion, and is expected to reach US$ 90.08 billion by 2031 at a CAGR of 25.80%.

An area of synthetic biology involves the fusion of multiple disciplines, including molecular biology, biotechnology, biophysics, genetic engineering, and others. A top-down approach is used primarily in synthetic biology, whereas a bottom-up approach is mainly used. For the top-down approach, existing biological systems are redesigned and fabricated for the purpose of producing synthetic products. As part of the bottom-up approach, bioengineers create bioengineered devices and systems from scratch that are not present in nature. It is evident that the synthetic biology industry arose out of a pressing need to understand the functions of genetic elements, cells, and biological processes. Pharmaceutical
diagnostics, energy, bioplastics, and environmental products developed in this new biological system are used across a wide range of industries. There are a number of factors driving the growth of the synthetic biology market, including government support, the proliferation of companies developing synthetic biology, and the decline of DNA sequencing and synthesizing costs. Rather than stimulating industry growth, bio-safety
bio-security concerns would impede it. In the future, synthetic biology will continue to pose a key challenge due to the misuse of technology or the possibility of pathogens being accidentally released into the atmosphere. In the market, however, there are lucrative opportunities due to rising demand for biofuels, growing awareness among emerging economies, and increasing R D investments for synthetic drugs and vaccines.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Synthetic Biology Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Synthetic Biology Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Thermo Fisher Scientific
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Novozymes A/S
  • Ginkgo Bioworks
  • Amyris
  • Precigen
  • GenScript Biotech Corporation
  • Twist Bioscience
  • Synthetic Genomics
  • Codexis
  • Synthego
  • Creative Enzymes
  • Eurofins Scientific
  • Cyrus Biotechnology
  • ATUM
  • TeselaGen
  • Arzeda
  • Integrated DNA Technologies
  • New England Biolabs
  • Royal DSM
  • OriGene Technologies
  • Genomatica
  • Illumina
  • Scarab Genomics

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Tool

  • Oligonucleotides and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Synthetic Cells
  • Chassis Organisms
  • Xeno-nucleic Acids

By Technology

  • Gene Synthesis
  • Genome Engineering
  • Sequencing
  • Bioinformatics
  • Site-directed Mutagenesis
  • Cloning
  • Measurement and Modeling
  • Microfluidics
  • Nanotechnology

By Application

  • Medical Application
    • Pharmaceuticals
    • Drug Discovery and Therapeutics
      • Cancer Detection and Diagnostics
      • Other Drug Discovery and Therapeutic Applications
  • Artificial Tissue and Tissue Regeneration
    • Bio-synthesis
    • Stem Cell Regulation
    • Other Tissue and Tissue Regeneration Applications
  • Industrial Applications
    • Biofuel and Renewable Energy
    • Biomaterials and Green Chemicals
    • Industrial Enzymes, by Application
      • Textile Industry
      • Paper Industry
      • Consumer Care Industry
        • Skin Care and Cosmetics
        • Other Consumer Care Products
      • Other Industries
  • Food and Agriculture
  • Environmental Applications
    • Bioremediation
    • Biosensing

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Synthetic Biology Market By Tool, By Technology, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Synthetic Biology Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Synthetic Biology Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Synthetic Biology Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Synthetic Biology Market, By Tool Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oligonucleotides and Synthetic DNA
        2. Enzymes
        3. Cloning Technologies Kits
        4. Synthetic Cells
        5. Chassis Organisms
        6. Xeno-nucleic Acids

  • 8.   Synthetic Biology Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Gene Synthesis
        2. Genome Engineering
        3. Sequencing
        4. Bioinformatics
        5. Site-directed Mutagenesis
        6. Cloning
        7. Measurement and Modeling
        8. Microfluidics
        9. Nanotechnology

  • 9.   Synthetic Biology Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Medical Application
         1.1. Pharmaceuticals
         1.2. Drug Discovery and Therapeutics
          1.2.1. Cancer Detection and Diagnostics
          1.2.2. Other Drug Discovery and Therapeutic Applications
        2. Artificial Tissue and Tissue Regeneration
         2.1. Bio-synthesis
         2.2. Stem Cell Regulation
         2.3. Other Tissue and Tissue Regeneration Applications
        3. Industrial Applications
         3.1. Biofuel and Renewable Energy
         3.2. Biomaterials and Green Chemicals
         3.3. Industrial Enzymes, by Application
          3.3.1. Textile Industry
          3.3.2. Paper Industry
          3.3.3. Consumer Care Industry
           3.3.3.1. Skin Care and Cosmetics
           3.3.3.2. Other Consumer Care Products
          3.3.4. Other Industries
        4. Food and Agriculture
        5. Environmental Applications
         5.1. Bioremediation
         5.2. Biosensing

  • 10.   North America Synthetic Biology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Synthetic Biology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Synthetic Biology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Synthetic Biology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Merck KGaA
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Agilent Technologies, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Novozymes A/S
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Ginkgo Bioworks
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Amyris
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Precigen
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. GenScript Biotech Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Twist Bioscience
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Synthetic Genomics
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Codexis
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Synthego
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Creative Enzymes
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Eurofins Scientific
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Cyrus Biotechnology
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16.ATUM
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17.TeselaGen
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18.Arzeda
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19.Integrated DNA Technologies
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20.New England Biolabs
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21.Royal DSM
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22.OriGene Technologies
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
        23.Genomatica
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
        24.Illumina
         24.1. Company Overview
         24.2. Product Portfolio
         24.3. SWOT Analysis
         24.4. Financial Overview
         24.5. Strategic Overview
        25.Scarab Genomics
         25.1. Company Overview
         25.2. Product Portfolio
         25.3. SWOT Analysis
         25.4. Financial Overview
         25.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients